+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Healthcare Licensing - Regional Trends: Japan-to-from-USA Mid-Year Review

  • ID: 4604829
  • Report
  • July 2018
  • Region: Global
  • 83 pages
  • FinGlobe, Inc
1 of 2
This mid-year review report brings at one place all the news for licensing deals and negotiations that took place between healthcare companies of Japan and the US during January 1, 2018 to June 30, 2018. The licensing trends and directions during this time period are also analyzed comprehensively.

Key features:
  • 6 months’ Japan-US healthcare licensing news at one place
  • Small, medium and big multinational/non-multinational companies covered
  • Curated categorizations of licensing news
  • 8+ variables reflecting different forms of transactions done
  • Licensing trends and directions summarized
The report is useful to:
  • Japan and US healthcare companies planning to introduce products in each other’s markets
  • Companies active in R&D and seeking new market base
  • Healthcare company executives negotiating licensing deals between Japan and US companies
  • Investors analyzing varied kinds of transaction options for licensing deals
Key analysis provided: January-June 2018
  • Total number of licensing deals from Japan companies to US companies
  • Total number of licensing deals from US companies to Japan companies
  • Total number of companies/institutes involved in Japan-US licensing deals
  • Most licensing deals signed by companies of which sub-industry within healthcare sector
  • Most licensing deals signed by which market capitalization group’s companies
  • Most licensing deals signed by which medicine groups
  • Licensing payment arrangements most followed in the licensing deals between Japanese and US companies
  • Number of domestic and worldwide licensing between Japanese and US companies
  • Number of R&D and commercialization licensing between Japanese and US companies
  • Number of licensing deals discontinued between Japanese and US companies
Note: Product cover images may vary from those shown
2 of 2
Introduction

Research Design

Section 1: Healthcare inventions licensed by Japan to United States
1.1 By Japanese company name
1.2 By US company name
1.3 By Sub-industry
1.4 By Market capitalization groups
1.5 By Terms of payment
1.6 By medical groups

Section 2: Healthcare inventions licensed by United States to Japan
2.1 By US company name
2.2 By Japanese company name
2.3 By Sub-industry
2.4 By Market capitalization groups
2.5 By Terms of payment
2.6 By medical groups

Section 3: Trends in Japan-US healthcare licensing deals
3.1 Healthcare sub-sector with most licensing deals
3.2 Market capitalization groups with most licensing deals
3.3 Healthcare companies most active in outbound and inbound licensing deals
3.4 Medical groups most active in licensing deals
3.5 Licensing payment arrangements most followed
3.6 Worldwide licensing vs domestic licensing
3.7 R&D licensing vs commercialization licensing
3.8 Licensing deals which discontinued

Section 4: Trends and directions

Appendices
Appendix 1 List of Japan-based companies/institutes covered in this report
Appendix 2 List of US-based companies/institutes covered in this report
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll